Human TNF alpha ELISA Kit, 2 x 96-well (pre-coated)

CAT#: EA102165

Human TNF alpha ELISA Kit, 2 x 96-well (pre-coated)

Size: 1 x 48 wells (pre-coated) 1 x 96 wells (pre-coated) 2 x 96 wells (pre-coated)



CNY 6,017.00


货期*
6周

规格
    • 2 x 96 wells (pre-coated)

Product images

Specifications

Product Data
Description Human TNF alpha ELISA Kit, 2 x 96-well (pre-coated)
Size 2 x 96 wells (pre-coated)
Format 2 x 96-well (pre-coated)
Assay Type Solid Phase Sandwich ELISA
Assay Length 3h40min
Signal Colorimetric
Curve Range 25-800 pg/ml
Sample Type Serum, Plasma, Cell culture supernatant
Sample Volume 100 µl
Specificity Recognizes both natural and recombinant human TNF-a
Sensitivity 10 pg/ml
Cross Reactivity No cross reactivity with other human cytokines. Cross reactivity with macac TNF-a. No interference with soluble TNFR I and TNFR II.
Components ELISA Kits include pre-coated strip plates, biotinylated secondary antibody, standards, controls (where applicable), buffers, streptavidin-HRP, TMB, stop reagents, and a detailed procedure.
Background This gene encodes a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. This cytokine is mainly secreted by macrophages. It can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. This cytokine is involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. This cytokine has been implicated in a variety of diseases, including autoimmune diseases, insulin resistance, and cancer. Knockout studies in mice also suggested the neuroprotective function of this cytokine. [provided by RefSeq, Jul 2008]
Gene Symbol TNF
Standard Curve
Representative Standard Curve
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Customer Reviews 
Loading...